Trial Reporting in ClinicalTrials.gov — The Final Rule

B) an amount equal to the modified workload adjustment factor for fiscal year 2007 (as determined under paragraph (3) ). '' (2) TYPES OF FEES. -Of the total revenue amount determined for a fiscal year under paragraph (1) -'' (A) one-third shall be derived from fees under subsection (a) (1) (relating to human drug applications and supplements) ; '' (B) one-third shall be derived from fees under subsection (a) (2) (relating to prescription drug establishments) ; and '' (C) one-third shall be derived from fees under subsection (a) (3) (relating to prescription drug products). '' (3) MODIFIED WORKLOAD ADJUSTMENT FACTOR FOR FISCAL YEAR 2007. -For purposes of paragraph (1) (B), the Secretary shall determine the modified workload adjustment factor by determining the dollar amount that results from applying the methodology that was in effect under subsection (c) (2) for fiscal year 2007 to the amount 354, 893, 000, except that, with respect to the portion of such determination that is based on the change in the total number of commercial investigational new drug applications, the Secretary shall count the number of such applications that were active during the most recent 12month period for which data on such submissions is available.